Idenix Pharmaceuticals, Inc., et al. v. Gilead Sciences, Inc., et al., C.A. Nos. 13-1987-LPS; C.A. No. 14-109-LPS; C.A. No. 14-846 - LPS, December 16, 2015.

Stark, C. J.  Court construes 5 terms from three patents.  A Markman hearing took place on October 19, 2015

The technology discloses a nucleoside compounds.  The following terms are construed:

1. “B-D-2'-C-branched”
2. “pyrimidine nucleoside”
3. “B-D-2'-C-branched pyrimidine ribonucleoside”
4. “B-D-2'-C-methylribofuranosyl nucleoside”
5. “Nucleoside”
6. “Administering”